|
|
|
| Effect of pharmaceutical care on the treatment effect and self-management behavior of patients with type 2 diabetes |
| LI Sijia1 LI Sainan1 PAN Ying1 CHEN Jia1 YANG Na2 |
1.Department of Pharmacy, the Third Hospital of Hebei Medical University, Hebei Province, Shijiazhuang 050051, China;
2.Department of Orthopedic Research Institution, the Third Hospital of Hebei Medical University, Hebei Province, Shijiazhuang 050051, China |
|
|
|
Abstract Objective To explore the effect of pharmaceutical care on the treatment effect and self-management behavior of patients with type 2 diabetes. Methods One hundred and thirty-two patients with type 2 diabetes admitted to the Third Hospital of Hebei Medical University from June 2018 to June 2019 were selected, they were divided into control group (n = 66, routine monitoring) and monitoring group (n = 66, pharmaceutical monitoring + routine monitoring) by random number table method, all patients were monitored for six months. Clinical indexes, drug compliance, incidence of irrational drug use, self-management, satisfaction with pharmaceutical care and incidence of hypoglycemia were compared between two groups. Results After intervention, the levels of 2-hour postprandial blood glucose, fasting plasma glucose, body mass index, glycosylated hemoglobin, systemic blood pressure, diastolic blood pressure in two groups were lower than those before intervention, and those in monitoring group were lower than those in control group (P < 0.05). Total compliance rate of monitoring group after intervention was higher than that of control group (P < 0.05). The incidence of irrational drug use in monitoring group after intervention was lower than that in control group (P < 0.05). The proportion of daily blood glucose monitoring, reasonable diet, medication compliance and adequate sleep in monitoring group after intervention was higher than that in control group (P < 0.05). There was no significant difference in the proportion of exercise rule between two groups after intervention (P > 0.05). After intervention, the total satisfaction of monitoring group was higher than that of control group (P < 0.05), and the incidence of hypoglycemia of monitoring group was lower than that of control group (P < 0.05). Conclusion The pharmaceutical care model developed in this study for type 2 diabetic patients is helpful to control blood glucose, promote rational drug use, significantly improve the self-management behavior of patients.
|
|
|
|
|
|
[1] 邓启凤，陈静，邹玉平，等.2型糖尿病患者合并糖尿病视网膜病变的危险因素分析[J].海军医学杂志，2020，41（2）：162-164.
[2] 段丽君，王健，韩静，等.天津市2型糖尿病慢性并发症流行病学研究[J].重庆医学，2019，48（22）：3874-3878.
[3] 任晓丽，刘娟，杨姣.2型糖尿病对甲减患者血脂心功能及心血管事件的影响[J].河北医学，2019，25（10）：1711-1715.
[4] 尹月，张艳华.临床药师参与贝伐珠单抗致血压升高的药学监护[J].临床药物治疗杂志，2018，16（7）：78-80.
[5] 周海琦，陈国栋.临床药师对高血压病合并糖尿病患者的药学监护[J].中国医院用药评价与分析，2018，18（3）：418-420.
[6] 刘泽玉，郑咏池，任强，等.类风湿关节炎合并肺结核患者的药学监护[J].中国药物应用与监测，2016，13（2）：95-98.
[7] 唐筱婉，唐彦，左玮，等.我国和WHO基本药物目录中治疗2型糖尿病药物比较分析[J].中国药师，2019，22（6）：1099-1102.
[8] 母义明，郭代红，刘皋林，等.临床药物治疗学内分泌代谢疾病[M].北京：人民卫生出版社，2017：145-149.
[9] 俞慧群，王珍珍，张淑燕，等.临床药师参与社区糖尿病慢病管理的效果评价[J].中国执业药师，2015，12（5）：12-16.
[10] 中华医学会糖尿病学分会.中国2型糖尿病防治指南（2017年版）[J].中华糖尿病杂志，2018，10（1）：4-67.
[11] 中华医学会内分泌学分会.中国成人2型糖尿病胰岛素促泌剂应用的专家共识[J].中华内分泌代谢杂志，2012， 28（4）：261-265.
[12] 母义明，纪立农，宁光，等.二甲双胍临床应用专家共识（2016年版）[J].中国糖尿病杂志，2016，24（10）：871-884.
[13] 中华医学会内分泌学分会.成人2型糖尿病胰岛素临床应用的中国专家共识[J].中华内分泌代谢杂志，2013， 29（1）：1-6.
[14] 李洪超，官海静，刘国恩.我国社区2型糖尿病患者用药依从性影响因素研究[J].中国药房，2019，30（24）：3448-3451.
[15] Chen JH，Ou HT，Lin TC，et al. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus：a randomized controlled trial [J]. Int J Clin Pharm，2016，38（1）：88-95.
[16] 施芳红，石卫峰.临床药师对1例2型糖尿病合并带状疱疹伴神经痛患者的药学监护[J].中国药师，2018，21（4）：675-677.
[17] 侯文民，杨立军.2型糖尿病肾病患者的药学监护[J].中国保健营养，2017，27（33）：264.
[18] 王志辉，季敏，孙子杭，等.药学服务对社区2型糖尿病患者用药安全性和有效性的影响研究[J].中国医院用药评价与分析，2019，19（7）：880-883.
[19] 张婷婷，巫俊平.药学服务在2型糖尿病患者中的应用效果[J].中国当代医药，2017，24（2）：174-176.
[20] 刘秀珍，李琪，王凤玲，等.药学干预对接受多药治疗2型糖尿病患者临床疗效及生活质量的影响[J].现代医药卫生，2017，33（5）：691-693.
[21] 门超，周玉刚，马国库.临床药师干预对2型糖尿病患者合理用药及健康管理的效果[J].中国医药导报，2018， 15（12）：163-166.
[22] 潘威，李明哲.临床药师参与2型糖尿病患者慢病管理指导效果分析[J].四川医学，2016，37（10）：1087-1090. |
|
|
|
